News | SPECT Imaging | August 27, 2018

Brain Study of 62,454 Scans Identifies Drives of Brain Aging

Schizophrenia, cannabis use and alcohol abuse are just several disorders that are related to accelerated brain aging

Brain Study of 62,454 Scans Identifies Drives of Brain Aging

August 27, 2018 — In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon emission computed tomography (SPECT) scans to investigate factors that accelerate brain aging. The study — conducted by scientists from Amen Clinics (Costa Mesa, Calif.), Google, Johns Hopkins University, University of California Los Angeles and the University of California San Francisco — encompassed more than 30,000 individuals from 9 months old to 105 years of age.

SPECT evaluates regional cerebral blood flow in the brain that is reduced in various disorders.

Lead author, psychiatrist Daniel G. Amen, M.D., founder of Amen Clinics, commented, “Based on one of the largest brain imaging studies ever done, we can now track common disorders and behaviors that prematurely age the brain. Better treatment of these disorders can slow or even halt the process of brain aging. The cannabis abuse finding was especially important, as our culture is starting to see marijuana as an innocuous substance. This study should give us pause about it.”

The current study used brain SPECT imaging to determine aging trajectories in the brain and which common brain disorders predict abnormally accelerated aging. It examined these functional neuroimaging scans from a large multi-site psychiatric clinic from patients who had many different psychiatric disorders, including bipolar disorder, schizophrenia and attention deficit hyperactivity disorder (ADHD).  

Researchers studied 128 brain regions to predict the chronological age of the patient. Older age predicted from the scan compared to the actual chronological age was interpreted as accelerated aging.  The study found that a number of brain disorders and behaviors predicted accelerated aging, especially:

  • Schizophrenia, which showed an average of 4 years of premature aging;
  • Cannabis abuse (2.8 years of accelerated aging);
  • Bipolar disorder (1.6 years accelerated aging);
  • ADHD (1.4 years accelerated aging); and
  • Alcohol abuse (0.6 years accelerated aging).  

Interestingly, the researchers did not observe accelerated aging in depression and aging, which they hypothesize may be due to different types of brain patterns for these disorders.

Commenting on the study, George Perry, Ph.D., chief scientist at the Brain Health Consortium from the University of Texas at San Antonio, said, “This is one of the first population-based imaging studies, and these large studies are essential to answer how to maintain brain structure and function during aging. The effect of modifiable and non-modifiable factors of brain aging will further guide advice to maintain cognitive function.”

Co-investigator Sachit Egan, Google Inc., said, “This paper represents an important step forward in our understanding of how the brain operates throughout the lifespan. The results indicate that we can predict an individual's age based on patterns of cerebral blood flow. Additionally, groundwork has been laid to further explore how common psychiatric disorders can influence healthy patterns of cerebral blood flow.”

The study is published in the Journal of Alzheimer’s Disease.

For more information: www.j-alz.com

Related Content

Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a...
Medtronic Recalls Synergy Cranial Software and Stealth Station S7 Cranial Software
News | Procedure Navigation Systems | February 05, 2019
Medtronic is recalling the Synergy Cranial Software and StealthStation S7 Cranial Software used with the StealthStation...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
Artificial Intelligence Research Receives RSNA Margulis Award
News | Digital Radiography (DR) | January 28, 2019
The Radiological Society of North America (RSNA) presented its seventh Alexander R. Margulis Award for Scientific...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.